Skip to main content
. 2022 May 18;14(5):1082. doi: 10.3390/v14051082

Figure 3.

Figure 3

Abnormalities of B cell development and maturation in SARS-CoV-2-infected patient. Lower relative and absolute numbers of circulating main B cell subsets were found in patients with COVID-19 if compared to control, but these patients exhibited elevated levels of circulating CD20–CD38highCD27high plasmablasts and CD21-negative B lymphocytes pointing to impaired maturation and differentiation of memory and effector B cells in peripheral lymphoid tissue.